GlobeNewswire Inc.··Ascentage Pharma Group InternationalAscentage Pharma Sets March 25 Earnings Call for 2025 Full-Year Results
Ascentage Pharma will report 2025 full-year unaudited results on March 25, 2026, with dual-language investor webcasts highlighting performance of its approved cancer therapies and clinical pipeline progress.
AAPGfinancial resultsclinical trials